

share
Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo CAS NO 618118-95-9
Unit Price:
CAS No.:618118-95-9
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo is a critical process-related impurity of the antiplatelet drug Eptifibatide, a cyclic heptapeptide. This compound is essential for pharmaceutical quality control and regulatory compliance, serving as a reference standard for method development and validation. It is primarily required by pharmaceutical manufacturers, analytical laboratories, and regulatory affairs departments involved in the synthesis, purification, and quality assurance of Eptifibatide API and its formulations.
Application
- Pharmaceutical Reference Standard: Used as a certified impurity standard for the identification and quantification of deamidated Eptifibatide in Active Pharmaceutical Ingredient (API) and finished drug products.
- Analytical Method Development: Critical for developing and validating stability-indicating HPLC/UPLC methods to monitor impurity profiles during drug development and manufacturing.
- Process Chemistry Research: Employed in studying degradation pathways and optimizing synthesis conditions to minimize the formation of this specific impurity.
- Regulatory Documentation: Supports the filing of regulatory dossiers (e.g., for FDA, EMA) by providing impurity characterization data required for drug approval.
- Quality Control (QC) Testing: Serves as a system suitability and calibration standard in routine QC release testing of Eptifibatide batches.
- Stability Studies: Used to assess the degradation kinetics of Eptifibatide under various stress conditions (e.g., heat, humidity, pH).
Basic Information
| Product Name | Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo |
| CAS No. | 618118-95-9 |
| Molecular Formula | C35H49N11O9S2 |
| Molecular Weight | 831.96 g/mol |
| Synonyms | Deamidated Eptifibatide; Eptifibatide Related Compound C; Integrilin Impurity 3; (3R,11S,17S,20S,25aS)-20-((1H-Indol-3-yl)methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carboxylic Acid; Nα-(3-Mercaptopropionyl)-N6-(carbamimidoyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic (1→6),(2→7)-disulfide (Deamidated Form); Cyclo(S,S)-[Mpr-Har-Gly-Asp-Trp-Pro-Cys]-OH (Deamidated); Eptifibatide Deamidation Product. |
| EINECS | Contact for details |
Quality Control
Our Eptifibatide impurity 3 is manufactured under strict quality systems suitable for use as a pharmaceutical reference standard. Each batch is characterized and qualified using advanced analytical techniques including HPLC, LC-MS, and NMR to ensure structural identity and high purity. Certificates of Analysis (COA) are provided, detailing batch-specific results for purity, impurities, and chromatographic profile. Our quality commitment aligns with the standards expected for pharmaceutical impurity standards used in GMP environments.
Storage
Preserve in a tightly closed container, protected from light. Store at -20°C or below for long-term stability. This product is hygroscopic (moisture-sensitive). Allow the vial to equilibrate to room temperature in a desiccator before opening to prevent condensation and moisture uptake. For short-term storage (up to one month), store at 2-8°C.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white solid |
| Identification (HPLC) | Retention time corresponds to reference standard |
| Identification (MS) | Mass spectrum consistent with molecular structure |
| Purity (HPLC, Area%) | ≥ 95.0% |
| Related Substances (HPLC) | Total impurities ≤ 5.0% Any single unknown impurity ≤ 1.0% |
| Water Content (KF) | ≤ 5.0% |
| Residual Solvents (GC) | Complies with ICH Q3C guidelines |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pregabalin Ep Impurity A CAS NO 181289-23-6


Sulfamethazine-N4-Acetyl CAS NO 100-90-3


Pseudomorphine (Morphine Impurity) CAS NO 125-24-6


Dextrorphan D-Tartrate CAS NO 125-73-5


8-Acetyl Ludaconitine CAS NO 127-29-7


Oxythiamine Hydrochloride CAS NO 136-16-3


Dl-Normetanephrine Hydrochloride CAS NO 1011-74-1


Hydrochlorothiazide Impurity G CAS NO 1025-75-8


Prednisone Impurity 24 CAS NO 1058-04-4


Cinepazide Impurity 5 CAS NO 1078-64-4


n-Nitrosodiethanolamine CAS NO 1116-54-7


10-Hydroxynortriptyline CAS NO 1156-99-6


Nicorandil Impurity 16 CAS NO 1157-74-0


16-Dehydro Pregnenolone Acetate Impurity 3 CAS NO 1173-11-1


17Beta-Hydroxy-4-Androsten-3-One 17-D-Glucuronide CAS NO 1180-25-2


6,6',12'-Trimethoxy-2-Methyloxyacanthan-7-Ol CAS NO 1183-76-2


Thiamine Impurity 27 CAS NO 1196-75-4


4-Hydroxytriamterene CAS NO 1226-52-4


Betamethasone Impurity 7 CAS NO 1249-19-0


Benzocaine Impurity D CAS NO 1333-08-0
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






